Last edition
News about "Regenerative Medicine Advanced Therapy"
Aspen Neuroscience's Parkinson's Cell Therapy Receives US FDA RMAT Designation
Aspen Neuroscience has received US FDA Regenerative Medicine Advanced Therapy designation for sasineprocel (ANPD001), its investigational autologous cell therapy for Parkinson's disease.
Regenerative Medicine Advanced Therapy | 31/07/2026 | By News Bureau | 108
FDA Clears Expanded Access Programme for StemCyte's RegeneCyte Therapy in Long covid Patients
The FDA has approved an Expanded Access programme for StemCyte’s RegeneCyte, enabling eligible Long covid patients to access the cord blood-based therapy amid ongoing clinical trials.
Regenerative Medicine Advanced Therapy | 27/01/2026 | By News Bureau | 320
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy